Cargando…
Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC)
BACKGROUND AND AIM: Despite the advances in oral anticoagulation with NOACs, careful patient and dose selection is required with NOAC therapy. Our study aimed to assess treatment patterns of NOACs in AF along with patients’ continuity to NOAC treatments in first year, and their knowledge level of AF...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897699/ https://www.ncbi.nlm.nih.gov/pubmed/35257027 http://dx.doi.org/10.1016/j.ijcha.2022.100989 |
_version_ | 1784663485084336128 |
---|---|
author | Badak, Özer Demir, Ali Rıza Önal, Tugay Akgün, Taylan Yontar, Osman Can Şatıroğlu, Ömer Duman, Hakan Okuyan, Ertuğrul Melek, Mehmet Dural, İbrahim Etem |
author_facet | Badak, Özer Demir, Ali Rıza Önal, Tugay Akgün, Taylan Yontar, Osman Can Şatıroğlu, Ömer Duman, Hakan Okuyan, Ertuğrul Melek, Mehmet Dural, İbrahim Etem |
author_sort | Badak, Özer |
collection | PubMed |
description | BACKGROUND AND AIM: Despite the advances in oral anticoagulation with NOACs, careful patient and dose selection is required with NOAC therapy. Our study aimed to assess treatment patterns of NOACs in AF along with patients’ continuity to NOAC treatments in first year, and their knowledge level of AF and NOAC treatment. METHODS: ASPECT-NOAC was designed as an observational, prospective, and multicenter study. AF patients who were prescribed NOACs within last four months were recruited from 34 outpatient cardiology clinics covering all geographic regions of Turkey. Baseline data were collected initially whereas patient awareness was evaluated at 3 to 4 weeks. Final study visit was performed at 12 months. RESULTS: In total, 991 patients were included to the study. Mean ± standard deviation of age was 69.4 ± 10.2 years and 53.0% of patients were female. Mean duration from AF diagnosis was 24.9 ± 50.9 months. Mean CHA(2)DS(2)-VASc and HAS-BLED scores were 3.1 ± 1.5 and 1.6 ± 1.1, respectively. AF disease and NOAC treatment knowledge levels were found to be 48.9 ± 23.1% and 73.0 ± 19.3%, respectively. Among reduced dose users 71.4% of patients were prescribed inappropriate reduced doses. Through the study follow-up, 32 patients (3.2%) deceased and NOAC therapy was discontinued in 74 patients (8.7%). CONCLUSION: AF patients who recently started NOAC treatment in Turkey were found to have variable knowledge about their disease and anticoagulation treatment. It was observed that most of the patients continued the NOAC treatment throughout the study. Reduced dosing of NOACs was common, which was associated with higher baseline risk for bleeding as well as stroke. |
format | Online Article Text |
id | pubmed-8897699 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-88976992022-03-06 Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC) Badak, Özer Demir, Ali Rıza Önal, Tugay Akgün, Taylan Yontar, Osman Can Şatıroğlu, Ömer Duman, Hakan Okuyan, Ertuğrul Melek, Mehmet Dural, İbrahim Etem Int J Cardiol Heart Vasc Original Paper BACKGROUND AND AIM: Despite the advances in oral anticoagulation with NOACs, careful patient and dose selection is required with NOAC therapy. Our study aimed to assess treatment patterns of NOACs in AF along with patients’ continuity to NOAC treatments in first year, and their knowledge level of AF and NOAC treatment. METHODS: ASPECT-NOAC was designed as an observational, prospective, and multicenter study. AF patients who were prescribed NOACs within last four months were recruited from 34 outpatient cardiology clinics covering all geographic regions of Turkey. Baseline data were collected initially whereas patient awareness was evaluated at 3 to 4 weeks. Final study visit was performed at 12 months. RESULTS: In total, 991 patients were included to the study. Mean ± standard deviation of age was 69.4 ± 10.2 years and 53.0% of patients were female. Mean duration from AF diagnosis was 24.9 ± 50.9 months. Mean CHA(2)DS(2)-VASc and HAS-BLED scores were 3.1 ± 1.5 and 1.6 ± 1.1, respectively. AF disease and NOAC treatment knowledge levels were found to be 48.9 ± 23.1% and 73.0 ± 19.3%, respectively. Among reduced dose users 71.4% of patients were prescribed inappropriate reduced doses. Through the study follow-up, 32 patients (3.2%) deceased and NOAC therapy was discontinued in 74 patients (8.7%). CONCLUSION: AF patients who recently started NOAC treatment in Turkey were found to have variable knowledge about their disease and anticoagulation treatment. It was observed that most of the patients continued the NOAC treatment throughout the study. Reduced dosing of NOACs was common, which was associated with higher baseline risk for bleeding as well as stroke. Elsevier 2022-03-02 /pmc/articles/PMC8897699/ /pubmed/35257027 http://dx.doi.org/10.1016/j.ijcha.2022.100989 Text en © 2022 Pfizer PFE. Published by Elsevier B.V. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Paper Badak, Özer Demir, Ali Rıza Önal, Tugay Akgün, Taylan Yontar, Osman Can Şatıroğlu, Ömer Duman, Hakan Okuyan, Ertuğrul Melek, Mehmet Dural, İbrahim Etem Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC) |
title | Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC) |
title_full | Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC) |
title_fullStr | Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC) |
title_full_unstemmed | Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC) |
title_short | Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC) |
title_sort | assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin k antagonist oral anticoagulants (aspect-noac) |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897699/ https://www.ncbi.nlm.nih.gov/pubmed/35257027 http://dx.doi.org/10.1016/j.ijcha.2022.100989 |
work_keys_str_mv | AT badakozer assessmentoftreatmentpatternsandpatientawarenessinatrialfibrillationpatientsusingnonvitaminkantagonistoralanticoagulantsaspectnoac AT demiralirıza assessmentoftreatmentpatternsandpatientawarenessinatrialfibrillationpatientsusingnonvitaminkantagonistoralanticoagulantsaspectnoac AT onaltugay assessmentoftreatmentpatternsandpatientawarenessinatrialfibrillationpatientsusingnonvitaminkantagonistoralanticoagulantsaspectnoac AT akguntaylan assessmentoftreatmentpatternsandpatientawarenessinatrialfibrillationpatientsusingnonvitaminkantagonistoralanticoagulantsaspectnoac AT yontarosmancan assessmentoftreatmentpatternsandpatientawarenessinatrialfibrillationpatientsusingnonvitaminkantagonistoralanticoagulantsaspectnoac AT satırogluomer assessmentoftreatmentpatternsandpatientawarenessinatrialfibrillationpatientsusingnonvitaminkantagonistoralanticoagulantsaspectnoac AT dumanhakan assessmentoftreatmentpatternsandpatientawarenessinatrialfibrillationpatientsusingnonvitaminkantagonistoralanticoagulantsaspectnoac AT okuyanertugrul assessmentoftreatmentpatternsandpatientawarenessinatrialfibrillationpatientsusingnonvitaminkantagonistoralanticoagulantsaspectnoac AT melekmehmet assessmentoftreatmentpatternsandpatientawarenessinatrialfibrillationpatientsusingnonvitaminkantagonistoralanticoagulantsaspectnoac AT duralibrahimetem assessmentoftreatmentpatternsandpatientawarenessinatrialfibrillationpatientsusingnonvitaminkantagonistoralanticoagulantsaspectnoac |